ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
12,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
15,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
16,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
19,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
19,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
21,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
22,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
23,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
28,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
33,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
35,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
36,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
36,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
36,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
38,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
38,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
39,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
40,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
41,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
42,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
43,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
44,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
45,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
45,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
46,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
49,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
55,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
57,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
59,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
62,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
63,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
65,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
67,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
68,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
69,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
69,2,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
69,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
70,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
71,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
72,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
73,1,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
74,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
75,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
75,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
77,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
79,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
80,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
81,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
82,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
82,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
82,3,Ear malformation,Ear disorders congenital NEC,Ear and labyrinthine disorders congenital,Cong,N
83,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
83,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
83,3,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
84,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
84,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
86,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
86,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
87,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
88,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
88,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
88,3,Urinary tract malformation,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
89,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
90,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
91,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
93,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
93,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
94,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
94,2,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
95,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
95,3,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
96,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
98,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
99,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
101,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
101,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
103,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
105,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
106,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
106,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
106,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,1,"Reproductive tract hypoplasia, male",Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
108,1,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
109,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
110,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
113,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
114,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
114,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
115,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
116,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
117,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
117,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
118,1,Porphyria,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
119,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
119,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
119,3,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
119,4,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
120,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
120,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
121,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
122,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
122,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
123,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
124,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
125,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
127,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
132,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
134,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Headache,Headaches NEC,Headaches,Nerv,N
136,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
137,1,Congenital brain damage,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
138,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
139,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
140,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
141,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
141,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
142,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
142,3,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
142,4,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
143,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
144,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
144,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
145,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
145,2,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
145,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
146,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
147,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
147,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
148,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
150,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
151,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
151,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
152,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
153,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
154,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
155,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
156,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
156,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
156,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
157,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
160,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
161,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
162,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
162,2,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
162,3,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
163,1,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
163,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
164,1,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
164,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
165,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
165,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
165,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
165,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
167,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
168,1,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
169,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
170,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
174,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
175,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
176,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
176,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
177,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
177,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
178,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
179,1,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
179,2,Hernia congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
180,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
180,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
180,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
182,1,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
183,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
184,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
185,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
185,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
185,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
185,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,1,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
187,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
188,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
188,2,Kyphosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
188,3,Myopathy,Myopathies,Muscle disorders,Musc,N
188,4,Neck deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
188,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
188,6,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
188,7,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
188,8,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
189,1,Headache,Headaches NEC,Headaches,Nerv,N
190,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
191,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
191,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
192,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
192,3,Rickets,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
193,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
193,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
193,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
194,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
194,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
195,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
196,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
197,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
198,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
198,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
199,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
199,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
199,3,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
199,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
200,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
201,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
201,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
201,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
201,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
202,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
202,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
203,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
203,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
204,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
205,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
206,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
206,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
206,3,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
206,4,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
207,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
207,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
207,4,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
208,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
208,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
209,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
209,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
210,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
212,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
213,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
213,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
213,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
214,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
214,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
214,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
214,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
214,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
215,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
216,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
216,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
216,3,Product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
216,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
217,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
217,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
217,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
217,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
218,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
218,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
220,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
220,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
220,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
220,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
220,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
221,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
221,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
222,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
222,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
222,4,Pyroglutamate increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
222,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
222,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
222,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,1,Epilepsia partialis continua,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,Y
224,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
224,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
224,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
224,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
224,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
224,7,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
224,8,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
225,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
225,3,Temporal lobe epilepsy,Partial complex seizures,Seizures (incl subtypes),Nerv,N
226,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
227,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
227,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
228,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
229,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
230,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
230,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
230,3,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
230,4,Congenital tracheomalacia,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
230,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
230,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
230,7,Kidney malformation,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
230,8,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
231,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
232,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,2,Headache,Headaches NEC,Headaches,Nerv,N
232,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
232,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
233,1,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
234,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
235,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
235,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
235,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
235,4,Headache,Headaches NEC,Headaches,Nerv,N
235,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
235,6,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
235,7,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
235,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
235,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
235,10,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
236,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
237,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
237,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
237,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
237,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
237,5,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
237,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
237,7,Headache,Headaches NEC,Headaches,Nerv,N
237,8,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
237,9,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
237,10,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
237,11,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
238,1,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
239,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
240,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
240,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
240,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
240,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
240,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
240,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
240,9,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
240,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
241,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
242,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
242,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,3,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
243,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
243,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
243,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
243,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
243,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
244,1,Anticonvulsant drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
244,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
244,3,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
244,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
244,5,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
244,6,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
244,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
244,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
245,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
245,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
245,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
245,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
245,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
245,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
245,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
245,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
246,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
247,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
247,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
248,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
248,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
249,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
249,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
249,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
250,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
250,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
250,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
250,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
250,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
250,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
251,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,1,Arachnoid cyst,Nervous system cysts and polyps,Nervous system neoplasms benign,Nerv,N
252,2,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
252,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,4,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
252,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
252,6,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
252,7,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
252,8,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
253,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
255,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
256,1,Deafness,Hearing losses,Hearing disorders,Ear,N
257,1,Deafness,Hearing losses,Hearing disorders,Ear,N
257,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
258,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
259,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
260,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
261,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
262,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
263,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
264,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
265,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
265,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
266,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
267,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
268,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
269,3,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
270,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
271,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
271,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
272,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
272,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
273,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
274,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
274,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
275,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
276,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
277,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
277,2,Mucosal disorder,Mucosal findings abnormal,General system disorders NEC,Genrl,N
277,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
277,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
277,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
278,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
279,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
280,1,CSF glucose decreased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
281,1,CSF glucose decreased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
281,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
282,2,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
283,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
283,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
283,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
284,1,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
285,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
285,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
287,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
287,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
287,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
287,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
288,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
288,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
288,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
289,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
289,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
289,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
290,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
290,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
290,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
290,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
290,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
290,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
290,7,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
290,8,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
290,9,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
293,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
293,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
293,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
293,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
293,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
293,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
294,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
294,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
295,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
295,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
295,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
298,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
299,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
299,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
299,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
299,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
300,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
300,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
300,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
300,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
301,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
301,2,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
301,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
301,4,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
301,5,Renal fusion anomaly,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
301,6,Right ventricular enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
301,7,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
302,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
302,4,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
302,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
303,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
303,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
304,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
304,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,1,Fracture pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
306,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
306,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
307,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
308,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
308,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
308,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
308,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
308,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
308,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
309,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
309,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
311,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
311,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
312,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
312,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
312,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
312,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
313,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
313,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
314,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
314,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
314,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
314,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
314,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
314,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
314,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
314,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
314,9,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
314,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
314,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
314,12,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
314,13,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
314,14,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
314,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
314,16,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
314,17,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
315,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
315,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
315,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
315,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
315,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
315,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
315,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
315,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
315,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
315,10,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
315,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
315,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
315,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
315,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
315,16,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
316,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
316,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
316,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
316,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
316,5,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
317,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
318,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
318,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
318,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
318,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
319,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
320,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
320,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
320,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
320,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
320,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
320,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
320,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
320,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
320,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
320,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
320,11,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
320,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
321,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
321,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
321,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
321,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
321,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
321,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
321,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
321,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
321,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
321,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
321,11,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
321,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
322,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
322,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
322,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
322,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
322,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
322,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
322,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
322,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
322,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
322,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
322,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
322,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
323,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
323,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
323,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
323,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
323,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
323,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
323,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
323,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
323,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,10,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
323,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
323,12,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
323,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
324,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
324,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
324,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
324,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
324,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
324,7,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
324,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
324,9,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
324,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
324,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
324,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
324,13,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
324,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
324,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
324,16,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
324,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
325,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
325,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
325,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
325,4,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
325,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
325,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
325,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
325,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
325,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
325,10,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
325,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
325,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
325,13,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
325,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
326,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
326,2,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
326,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
326,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
326,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
326,6,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
326,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,8,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
326,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
327,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
327,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
327,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
327,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
327,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
327,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
327,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
327,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
327,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
327,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
327,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
328,1,CSF glucose decreased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
329,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
329,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
329,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
329,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
329,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
329,7,Headache,Headaches NEC,Headaches,Nerv,N
329,8,Hypometabolism,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
329,9,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
329,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
329,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
329,12,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
329,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
329,14,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Pyroglutamic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
333,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
336,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
336,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
337,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
338,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
338,2,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
339,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
339,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
339,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
339,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
339,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
339,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
339,7,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
339,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
339,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
339,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
339,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
339,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
339,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
340,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
341,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
341,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
341,3,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
341,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
341,5,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
341,6,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
341,7,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
341,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
341,9,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
341,10,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
341,11,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
341,12,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
341,13,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
341,14,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
341,15,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
341,16,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
341,17,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
341,18,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
341,19,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
341,20,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,21,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
341,22,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
341,23,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
341,24,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
341,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
341,26,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
341,27,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
341,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
341,29,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,30,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
341,31,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
341,32,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
342,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
343,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
344,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
347,2,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
347,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
347,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
347,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
347,6,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
347,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
347,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
347,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
347,10,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
347,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
348,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
349,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
350,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
351,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
352,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
353,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
358,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,2,Heart block congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
361,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
361,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
364,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
365,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
367,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
368,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
368,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
369,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
370,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
370,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
370,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
370,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
